Navigation Links
UCLA-led team may have found key to cause of Cushing disease
Date:5/31/2013

FINDINGS:

Cushing disease is a life-threatening disorder most commonly triggered by tumors, often benign, in the pituitary glands, resulting in excess production of adrenocorticotrophic hormone (ACTH). The condition is marked by progressive weight gain, excessive fatty tissue deposits and a rounding of facial features, known as "moon face," and can lead to diabetes, hypertension, osteoporosis, obesity and psychological disturbances.

Cushing disease, which is more common in women than men, is also associated with a three- to four-fold increase in the risk of premature death. But what drives the tumor growth and the excess production of ACTH?

UCLA researchers and their colleagues have now found that testicular orphan nuclear receptor 4 (TR4) is overexpressed in the tumors. The scientists discovered that by knocking down TR4 in lab mice, they were able to reverse tumor growth and excess ACTH production.

IMPACT:

The findings could potentially lead to a drug therapy for Cushing disease.

AUTHORS:

Study authors included Li Du, Marvin Bergsneider, Leili Mirsadraei, Steven H. Young, William H. Yong and Anthony P. Heaney of UCLA; Johan W. Jonker of the University of Groningen in the Netherlands; and Michael Downes and Ronald M. Evans of Gene Expression Laboratory at the Salk Insitute of Biological Studies in La Jolla, Calif.

JOURNAL:

The findings were published in the May 21 issue of the journal Proceedings of the National Academy of Sciences.

FUNDING:

The research was supported by the National Institutes of Health (grants DK057978, HL105278, DK090962, HL088093, ES010337 and CA014195), the Helmsley Charitable Trust, the Samuel Waxman Cancer Research Foundation, UCLA's Jonsson Comprehensive Cancer Center, Ipsen/Biomeasure, the Human Frontier Science Program (grant CDA00013/2011-C), and the Netherlands Organization for Scientific Research (VIDI grant 016.126.338).


'/>"/>

Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-794-2273
University of California - Los Angeles Health Sciences
Source:Eurekalert

Related medicine news :

1. UCLA-led project aimed at African American couples affected by HIV gets $2.5 million boost
2. Charity Navigator Awards the Mesothelioma Applied Research Foundation with 4-Star Rating
3. Wheelock Honors Haiti Fund Co-Founder Karen Keating Ansara, Global Fund For Women, And The Singapore Government For International Achievements
4. Kessler Foundations Elaine Katz presents at national summit on disability employment
5. OKeeffe Foundation donates $250,000 to fund Scripps Florida neuroscience training program
6. BioPlus Specialty Pharmacy Founder and CEO Selected as Finalist in Ernst & Young Florida Entrepreneur of the Year Award
7. OsteoVantage™ Receives Supplemental Grant from the National Science Foundation
8. Queens University receives Bill and Melinda Gates Foundation grants
9. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Now Offer New Guided Weight Loss Tips Now Found in New Study to Help Patients Lose Weight Fast
10. The International Essential Tremor Foundation Honored as 2013 Top-Rated Nonprofit
11. Joe Jones, Personal Trainer to Seva Call Founder Shares Tips on Overcoming Gym Intimidation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... Ridgecrest Herbals makes it a ... new strategies to reduce waste, and support renewable energy. They believe this is a ... nature to find solutions for health issues, and maintain that destroying the environment in ...
(Date:4/24/2017)... ... 2017 , ... The California Dental Association Foundation’s two-day volunteer dental clinic, ... during the April 22-23 event at the San Mateo Event Center. , In ... care, CDA Cares educates the public and policymakers about the importance of good oral ...
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class ... support to bring their novel lifesaving device for the everyday use of parents ... sensors, specially designed to read a child’s vital signs, and detect unusual symptoms ...
(Date:4/24/2017)... ... April 24, 2017 , ... In ... be diagnosed globally; approximately 25,000 of them will be malignant.(1) As research into ... this type of healthcare model in the diagnosis and treatment of brain tumors. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Come to PAINWeekEnd (PWE) Tampa ... Walter Blvd, for an educational and exciting 2-day program. , An attendee at ... this before they approach patients” about the course entitled Ain't Misbehavin': Decreasing and Managing ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., a ... drug prescribing process, today announced it closed $25 million in ... venture capital firm based in Seattle ... Venture Partners . The Series B round included participation from ... in 2014, and GV (formerly Google Ventures). As ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
(Date:4/19/2017)... VANCOUVER , April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) ... the Bloom Burton & Co. Healthcare Investor Conference 2017 at the ... Edward Wright , Chief Executive Officer of the Company is ... Company,s CFO, Richard Bear and the Chairman of the ... ...
Breaking Medicine Technology: